Cardinal Health (NYSE:CAH) Given New $136.00 Price Target at Wells Fargo & Company

Cardinal Health (NYSE:CAH) had its target price increased by Wells Fargo & Company from $135.00 to $136.00 in a research note released on Tuesday morning,Benzinga reports. They currently have an equal weight rating on the stock.

Several other research firms have also weighed in on CAH. Deutsche Bank Aktiengesellschaft upped their price objective on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research report on Tuesday, January 7th. Mizuho began coverage on Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective for the company. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their target price for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $135.93.

Cardinal Health Trading Down 0.0 %

Shares of NYSE:CAH opened at $125.29 on Tuesday. The business’s 50 day moving average is $122.16 and its 200-day moving average is $114.75. The firm has a market capitalization of $30.27 billion, a PE ratio of 23.38, a PEG ratio of 1.46 and a beta of 0.63. Cardinal Health has a 1-year low of $93.17 and a 1-year high of $132.84.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, sell-side analysts predict that Cardinal Health will post 7.92 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.61%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio is 37.69%.

Institutional Investors Weigh In On Cardinal Health

Institutional investors and hedge funds have recently made changes to their positions in the company. Eastern Bank acquired a new stake in Cardinal Health in the third quarter worth about $25,000. Frazier Financial Advisors LLC grew its position in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares during the period. Hara Capital LLC bought a new stake in shares of Cardinal Health during the third quarter worth approximately $31,000. AM Squared Ltd acquired a new position in Cardinal Health in the third quarter valued at approximately $33,000. Finally, Kentucky Trust Co bought a new position in Cardinal Health in the fourth quarter valued at approximately $41,000. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.